Gamberini MR - Search Results

1

Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial.

Gamberini MR, Fortini M, Stievano A, Calori E, Riontino MV, Ceccherelli G, Venturelli D, Chicchi R, Biguzzi R, Fagnoni F, Portararo GA, Lasagni D, Borotti E, Buonocore R, Govoni M, Reverberi R. Gamberini MR, et al. Transfusion. 2021 Jun;61(6):1729-1739. doi: 10.1111/trf.16432. Epub 2021 May 4. Transfusion. 2021. PMID: 33948969 Free PMC article. Clinical Trial.

2

Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients.

Gamberini MR, Fortini M, Gilli G, Testa MR, De Sanctis V. Gamberini MR, et al. J Pediatr Endocrinol Metab. 1998;11 Suppl 3:867-9. J Pediatr Endocrinol Metab. 1998. PMID: 10091159

3

Left ventricular remodeling, systolic function, and diastolic function in young adults with beta-thalassemia intermedia: a Doppler echocardiography study.

Vaccari M, Crepaz R, Fortini M, Gamberini MR, Scarcia S, Pitscheider W, Bosi G. Vaccari M, et al. Among authors: gamberini mr. Chest. 2002 Feb;121(2):506-12. doi: 10.1378/chest.121.2.506. Chest. 2002. PMID: 11834665

4

HCV and HGV infection, iron overload and liver disease in multitransfused patients with thalassaemia and persistently normal or abnormal transaminase levels.

Gamberini MR, Francesconi R, Fortini M, Cavazzini L, Lari F, Scapoli C, Ballardini G, De Sanctis V, Bianchi FB. Gamberini MR, et al. Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:259-66. Pediatr Endocrinol Rev. 2004. PMID: 16462707

5

Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center.

Gamberini MR, Fortini M, De Sanctis V, Gilli G, Testa MR. Gamberini MR, et al. Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:285-91. Pediatr Endocrinol Rev. 2004. PMID: 16462713

6

Paraplegia due to spinal cord compression by extramedullary erythropoietic tissue in a thalassaemia intermedia patient with gynecomastia secondary to cirrhosis: successful treatment with hydroxyurea.

Gamberini MR, Fortini M, De Sanctis V. Gamberini MR, et al. Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:316-8. Pediatr Endocrinol Rev. 2004. PMID: 16462720

7

Healing of leg ulcers with hydroxyurea in thalassaemia intermedia patients with associated endocrine complications.

Gamberini MR, Fortini M, De Sanctis V. Gamberini MR, et al. Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:319-22. Pediatr Endocrinol Rev. 2004. PMID: 16462721

8

Chelation therapy and bone metabolism markers in thalassemia major.

Pratelli L, Verri E, Fortini M, Marconi S, Zolezzi C, Fornasari PM, Gamberini MR, De Sanctis V. Pratelli L, et al. Among authors: gamberini mr. J Pediatr Endocrinol Metab. 2006 Nov;19(11):1335-42. doi: 10.1515/jpem.2006.19.11.1335. J Pediatr Endocrinol Metab. 2006. PMID: 17220062

9

Spermatozoal DNA damage in patients with B thalassaemia syndromes.

De Sanctis V, Perera D, Katz M, Fortini M, Gamberini MR. De Sanctis V, et al. Among authors: gamberini mr. Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:185-9. Pediatr Endocrinol Rev. 2008. PMID: 19337176

10

Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia.

Piga A, Perrotta S, Gamberini MR, Voskaridou E, Melpignano A, Filosa A, Caruso V, Pietrangelo A, Longo F, Tartaglione I, Borgna-Pignatti C, Zhang X, Laadem A, Sherman ML, Attie KM. Piga A, et al. Among authors: gamberini mr. Blood. 2019 Mar 21;133(12):1279-1289. doi: 10.1182/blood-2018-10-879247. Epub 2019 Jan 7. Blood. 2019. PMID: 30617198 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page